Moderna (MRNA) Financials: Income Statement, Balance Sheet & Cash Flow
Moderna, Inc.'s filed statements, straight from SEC EDGAR XBRL data — GAAP as filed, never a vendor normalization. Moderna, Inc.'s fiscal year ends in December; all periods below use the company's own fiscal calendar with exact reported period-end dates. Derived figures (Q4 residuals, quarterly cash flows) are flagged wherever they appear. Start with the joined MRNA stock intelligence profile for price regime, options history and manager ownership. Cross-check the tape on the chart and manager positioning on the 13F Consensus Tracker.
Latest quarter in plain English
In Q2 FY2026 (ended 2026-06-30), Moderna reported revenue of $145M (+2.1% vs Q2 FY2025) and net income of −$782M (+5.2% YoY). Free cash flow (CFO − capex) was −$563M. Diluted EPS: $-1.97. All figures GAAP as filed with the SEC; data refreshes each earnings season.
Sources, methodology & freshnessLast updated 2026-08-21 · Open ↓Close ↑
Source
SEC EDGAR XBRL company facts (10-Q / 10-K structured data), per-company concept maps maintained by hand
Methodology
Latest-filed value per period; Q4 income and quarterly cash flows derived and flagged; fiscal calendars preserved; GAAP only; blanks never estimated
Updates
Manual, each earnings season (python3 scripts/fetch-financials.py) — deliberately outside the daily pipelineLast: 2026-08-21
Maintained & reviewed by Yuriy Matso — methodology shown on the page.
MRNA · Q2 FY2026ended 2026-06-30
$145M
revenue +2.1% YoY
GAAP, as filed with the SEC — derived quarter (Q4 residual / YTD-differenced flows).
Net income
−$782M
Free cash flow
−$563M
Gross margin
—
01
Revenue & profit — the quarterly picture
The last 16 fiscal quarters of revenue and net income, as filed. Fourth quarters are derived (fiscal year minus nine months) and included; the tables below flag them.
02
Income statement
The last six fiscal quarters (YoY compares the latest quarter with the same fiscal quarter a year earlier), then the annual history.
| Line item | Q2 FY2026 | Q1 FY2026 | Q4 FY2025* | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | $145M | $389M | $678M | $1.0B | $142M | $108M | +2.1% |
| Cost of revenue | $93M | $955M | $452M | $207M | $119M | $90M | -21.8% |
| Gross profit | — | — | — | — | — | — | — |
| R&D | $651M | $649M | $775M | $801M | $700M | $856M | -7.0% |
| SG&A | $216M | $173M | $308M | $268M | $230M | $212M | -6.1% |
| Operating income | −$815M | −$1.4B | −$857M | −$260M | −$907M | −$1.1B | +10.1% |
| Other income (incl. investment gains) | −$19M | −$18M | −$12M | $0 | $8M | −$4M | -337.5% |
| Pre-tax income | −$767M | −$1.3B | −$799M | −$187M | −$818M | −$964M | +6.2% |
| Income tax | $15M | $9M | $27M | $13M | $7M | $7M | +114.3% |
| Net income | −$782M | −$1.3B | −$826M | −$200M | −$825M | −$971M | +5.2% |
| Diluted EPS | -1.97 | -3.40 | — | -0.51 | -2.13 | -2.52 | +7.5% |
| Diluted shares | 398M | 395M | — | 390M | 388M | 386M | +2.6% |
* period includes derived figures — Q4 = fiscal year − nine months; quarterly cash flows differenced from the cumulative year-to-date statements 10-Qs file. Diluted EPS is never derived (share counts differ per quarter), so derived quarters show no EPS.
Annual
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $3.2B | $6.8B | $19.3B | $18.5B | $803M | $60M | $135M |
| Cost of revenue | $868M | $1.5B | $4.7B | $5.4B | $2.6B | $8M | $0 | $0 |
| Gross profit | — | — | — | — | — | — | — | — |
| R&D | $3.1B | $4.5B | $4.8B | $3.3B | $2.0B | $1.4B | $496M | $454M |
| SG&A | $1.0B | $1.2B | $1.5B | $1.1B | $567M | $188M | $110M | $94M |
| Operating income | −$3.1B | −$3.9B | −$4.2B | $9.4B | $13.3B | −$763M | −$546M | −$413M |
| Other income (incl. investment gains) | −$8M | −$87M | −$124M | −$45M | −$29M | −$6M | −$8M | $2M |
| Pre-tax income | −$2.8B | −$3.6B | −$3.9B | $9.6B | $13.3B | −$744M | −$515M | −$384M |
| Income tax | $54M | −$46M | $772M | $1.2B | $1.1B | $3M | −$1M | $326,000 |
| Net income | −$2.8B | −$3.6B | −$4.7B | $8.4B | $12.2B | −$747M | −$514M | −$385M |
| Diluted EPS | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 | -1.96 | -1.55 | — |
| Diluted shares | 389M | 384M | 382M | 416M | 431M | 381M | 331M | — |
03
Balance sheet
Point-in-time positions at each period end — nothing here is derived. Long-term debt is the filed noncurrent line only; a cross-company "total debt" composite is deliberately not constructed.
| Line item | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.7B | $1.9B | $2.6B | $1.1B | $1.3B | $1.6B |
| Short-term investments | $3.4B | $3.3B | $3.2B | $3.4B | $3.9B | $4.4B |
| Total current assets | $5.8B | $5.8B | $6.5B | $6.6B | $6.2B | $6.8B |
| Total assets | $11.0B | $11.5B | $12.3B | $12.1B | $12.0B | $12.7B |
| Total current liabilities | $2.5B | $2.4B | $2.0B | $1.7B | $1.6B | $1.6B |
| Long-term debt | $591M | $590M | $590M | — | — | — |
| Total liabilities | $4.2B | $4.1B | $3.7B | $2.8B | $2.6B | $2.6B |
| Stockholders’ equity | $6.8B | $7.4B | $8.7B | $9.3B | $9.4B | $10.1B |
Annual
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.6B | $1.9B | $2.9B | $3.2B | $6.8B | $2.6B | $236M | $658M |
| Short-term investments | $3.2B | $5.1B | $5.7B | $6.7B | $3.9B | $2.0B | $867M | $863M |
| Total current assets | $6.5B | $8.1B | $10.3B | $13.4B | $16.1B | $6.3B | $1.1B | $1.6B |
| Total assets | $12.3B | $14.1B | $18.4B | $25.9B | $24.7B | $7.3B | $1.6B | $2.0B |
| Total current liabilities | $2.0B | $2.2B | $3.0B | $4.9B | $9.1B | $4.4B | $143M | $223M |
| Long-term debt | $590M | $0 | — | — | — | — | — | — |
| Total liabilities | $3.7B | $3.2B | $4.6B | $6.7B | $10.5B | $4.8B | $415M | $432M |
| Stockholders’ equity | $8.7B | $10.9B | $13.9B | $19.1B | $14.1B | $2.6B | $1.2B | $1.5B |
04
Cash flow & free cash flow
10-Qs file cash flow statements as cumulative year-to-date periods, so the quarterly figures here are differenced from consecutive filings and flagged. Free cash flow is the common convention — operating cash flow minus capital expenditures — computed from the two filed lines.
| Line item | Q2 FY2026* | Q1 FY2026 | Q4 FY2025* | Q3 FY2025* | Q2 FY2025* | Q1 FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | −$526M | −$630M | $930M | −$847M | −$919M | −$1.0B |
| Capital expenditures | $37M | $62M | $39M | $33M | $3M | $117M |
| Free cash flow (CFO − capex) | −$563M | −$692M | $891M | −$880M | −$922M | −$1.2B |
| Share buybacks | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| D&A | $56M | $56M | $66M | $51M | $56M | $38M |
* period includes derived figures — Q4 = fiscal year − nine months; quarterly cash flows differenced from the cumulative year-to-date statements 10-Qs file. Diluted EPS is never derived (share counts differ per quarter), so derived quarters show no EPS.
Annual
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$1.9B | −$3.0B | −$3.1B | $5.0B | $13.6B | $2.0B | −$459M | −$331M |
| Capital expenditures | $192M | $1.1B | $707M | $400M | $284M | $68M | $32M | $106M |
| Free cash flow (CFO − capex) | −$2.1B | −$4.1B | −$3.8B | $4.6B | $13.3B | $2.0B | −$491M | −$437M |
| Share buybacks | $2M | $0 | $1.2B | $3.3B | $857M | $0 | $0 | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| D&A | $211M | $185M | $617M | $348M | $232M | $31M | $31M | $25M |
05
Data provenance
XBRL concepts behind each line itemOpen ↓Close ↑
income
revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
cost_of_revenue: CostOfGoodsAndServicesSold
rnd: ResearchAndDevelopmentExpense
opex_sga: GeneralAndAdministrativeExpense
operating_income: OperatingIncomeLoss
other_income: OtherNonoperatingIncomeExpense
pretax_income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
income_tax: IncomeTaxExpenseBenefit
net_income: NetIncomeLoss
eps_diluted: EarningsPerShareDiluted
shares_diluted: WeightedAverageNumberOfDilutedSharesOutstanding
balance
cash_and_equivalents: CashAndCashEquivalentsAtCarryingValue
short_term_investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
total_current_assets: AssetsCurrent
total_assets: Assets
total_current_liabilities: LiabilitiesCurrent
long_term_debt: LongTermDebtNoncurrent
total_liabilities: Liabilities
stockholders_equity: StockholdersEquity
cashflow
cfo: NetCashProvidedByUsedInOperatingActivities
capex: PaymentsToAcquirePropertyPlantAndEquipment
buybacks: PaymentsForRepurchaseOfCommonStock
depreciation_amortization: DepreciationDepletionAndAmortization
Source: SEC EDGAR companyfacts for CIK 1682852 (Moderna, Inc.). Latest-filed value per period; blanks are lines the company did not report under any mapped concept — never estimated.
How Moderna Financials Works
- 1Pull company facts from SEC EDGAREach covered company's full XBRL fact history comes from the SEC's keyless companyfacts API — the same numbers the company filed in its 10-Qs and 10-Ks, with no third-party normalization. Every company tags its statements differently, so each stock has an explicit per-line concept map maintained by hand.
- 2Resolve each period to one valueThe same figure appears in multiple filings — the original quarter, the annual report, later comparative columns, sometimes restated. Each (period, line) resolves to the latest-filed value, so restatements and split-adjusted comparatives win, and the filing date kept is recorded.
- 3Derive what companies never fileNo company files a Q4 income statement — the fourth quarter is computed as the fiscal year minus the first nine months. Quarterly cash flows are differenced from the cumulative year-to-date statements 10-Qs actually contain. Every derived figure is flagged on the page; per-share numbers are never derived because share counts differ per quarter.
- 4Respect the fiscal calendarCovered companies end their years in different months (NVIDIA in late January, Apple in late September) and some use 52/53-week calendars. Periods are labeled with each company's own fiscal quarters and exact reported end dates — never forced onto calendar quarters.
Who Uses Moderna Financials
Earnings-season readers
See the new quarter in context the press release never gives: the full quarterly history behind it, margins over time, and how the cash flow compares to the reported profit.
Long-term holders
The annual tables are the decade view — revenue, margins, share count and free cash flow across fiscal years, as filed with the SEC rather than as summarized by a data vendor.
Narrative checkers
When a claim circulates about a company's spending, buybacks or cash position, the filed number is here with its statement, period and derivation status.
Cross-tool researchers
Names surfaced by the 13F consensus, momentum or flow tools link here where covered — positioning and price action on one side, the filed fundamentals on the other.
Pro Tips
01
GAAP will not match the headline number
Press releases lead with adjusted (non-GAAP) figures; these tables are GAAP as filed. A large gap between the two — usually stock compensation or one-time items — is itself information.
02
Watch the derived-quarter flags
Fourth quarters are computed (fiscal year minus nine months), so a Q4 anomaly can reflect a full-year true-up landing in the residual rather than something that happened in the quarter.
03
Free cash flow is a convention
FCF here is operating cash flow minus capital expenditures — the common definition, but not the only one. Companies with heavy finance leases or capitalized content spend (streaming, cloud) can look different under other definitions.
04
Compare fiscal quarters, not calendar quarters
A company with a January year-end reports its "Q4" holiday quarter when others report Q1. Cross-company comparisons should match period end dates, which every table here shows.
Common Issues & Solutions
The latest quarter is missing▾
This dataset refreshes manually each earnings season, outside the daily pipeline — a new 10-Q can post to EDGAR days before the refresh runs. The as-of date on each page states the data vintage.
A number differs from the earnings press release▾
These are GAAP figures from the XBRL filing. Press releases usually lead with non-GAAP adjusted numbers, and occasionally a figure is restated in a later filing — the latest-filed value wins here.
A line item is blank for some periods▾
Companies change what they disclose and how they tag it. A blank cell means the company did not report that line for that period under any mapped concept — blanks are never filled with estimates.
Old per-share figures look inconsistent with today's▾
Stock splits restate recent comparatives but not the deep history in SEC data. Per-share series are adjusted to the current share basis where a documented split table exists; any remaining discontinuity is a data limitation and reflects no real move.
Frequently Asked Questions
Where do these numbers come from?▾
Directly from each company's SEC filings via the EDGAR XBRL company-facts API — the structured data inside 10-Qs and 10-Ks. No third-party fundamentals vendor sits in between, and each company's tagging quirks are mapped by hand.
Why is Q4 marked as derived?▾
Companies never file a standalone fourth-quarter income statement — the 10-K covers the full year. Q4 is computed as the fiscal year minus the sum of the three reported quarters, which is standard practice; the flag exists so you know which figures were computed rather than read from a filing.
Why do quarterly cash flow numbers need special handling?▾
Cash flow statements in 10-Qs are cumulative year-to-date — the second quarter's filing covers six months. Quarterly figures are the differences between consecutive year-to-date statements, and they are flagged as derived.
Are these GAAP or adjusted numbers?▾
GAAP, as filed. Adjusted (non-GAAP) figures companies highlight in press releases — excluding stock compensation and one-time items — are not in the structured filing data and are not shown.
How often does this update?▾
Manually each earnings season, after covered companies file. This dataset deliberately runs outside the site's daily pipeline: fundamentals change four times a year, and each refresh is validated against known reported figures before it ships.
What does free cash flow mean here?▾
Operating cash flow minus capital expenditures, computed from the two filed lines and labeled as a convention. It is the most common FCF definition but not the only one.
Explore Other Tools
13F Consensus Tracker
Which tracked fund managers hold and trade these names each quarter.
Buyback & Dilution Tracker
Share-count changes across the top ~500 US stocks from the same EDGAR XBRL source.
Earnings Calendar
When the next report lands, and how the market reacted to the last one.
Momentum Scanner
How the stock is actually trading while the fundamentals print.
Last updated: 2026-08-21